Market cap
₹194 Cr
Revenue (TTM)
₹16 Cr
P/E Ratio
38.3
P/B Ratio
5.5
Div. Yield
0 %
Quality Score
9/10
Growth Score
6/10
Valuation Score
6/10
Momentum Score
UNRATED/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹3 Cr
-
ROE
81.2 %
-
ROCE
56.7 %
-
Industry P/E
49.21
-
EV/EBITDA
28.3
-
Debt to Equity
0.7
-
Book Value
₹11
-
EPS
₹5.4
-
Face value
10
-
Shares outstanding
7,240,000
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Accretion Nutraveda
| -- | 2.9 | 44.4 | -- | -- | -- | -- |
|
BSE Healthcare*
| 8.1 | -0.5 | 9.8 | 6.7 | 23.6 | 13.1 | 12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Accretion Nutraveda
|
268.5 | 194.4 | 16.0 | 2.6 | -- | 81.2 | 38.3 | 5.5 |
| 1,038.5 | 12,856.3 | 2,551.8 | 564.5 | 28.3 | 18.4 | 22.8 | 3.9 | |
| 505.2 | 8,799.0 | 947.3 | 247.8 | 28.5 | 18.9 | 35.5 | 6.5 | |
| 1,368.8 | 14,306.8 | 1,054.9 | 256.3 | 27.8 | 13.7 | 54.8 | 7.1 | |
| 1,732.2 | 32,734.3 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.4 | 6.6 | |
| 16,673.0 | 21,975.0 | 2,023.0 | 364.0 | 23.9 | 20.8 | 60.4 | 11.7 | |
| 930.5 | 4,880.7 | 811.3 | 21.0 | 0.7 | 2.1 | 237.5 | 3.8 | |
| 1,254.1 | 5,809.2 | 649.5 | 121.6 | 23.7 | 13.2 | 50.4 | 6.2 | |
| 830.4 | 9,575.2 | 502.0 | 138.7 | -- | 32.8 | 55.4 | 10.8 | |
| 261.3 | 6,896.3 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 11.7 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Accretion Nutraveda
--
-
Incorporated
2021
-
Chairman
--
-
Managing Director
Mayur Popatlal Sojitra
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Accretion Nutraveda Ltd’s IPO? Explore our IPO Details page.
Announcements
View AnnouncementsAppointment Of Internal Auditors
08-May-2026Appointment Of Secretarial Auditors
08-May-2026Clarification On Price Movement
30-Apr-2026No News & Announcements are available.
FAQs for Accretion Nutraveda
What is the current share price of Accretion Nutraveda Ltd Today?
The share price of Accretion Nutraveda Ltd is ₹268.50 (BSE) as of 15-Jun-2026 IST. Accretion Nutraveda Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Accretion Nutraveda Ltd?
The P/E ratio of Accretion Nutraveda Ltd is 38.35 times as on 15-Jun-2026, a 22 discount to its peers’ median range of 49.21 times.
The P/B ratio of Accretion Nutraveda Ltd is 5.48 times as on 15-Jun-2026, a 7 premium to its peers’ median range of 5.10 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
What is the 52 Week High and Low of Accretion Nutraveda Ltd?
The 52-week high and low of Accretion Nutraveda Ltd are Rs 300.00 and Rs 150.10 as of 16-Jun-2026.
What is the market cap of Accretion Nutraveda Ltd?
Accretion Nutraveda Ltd has a market capitalisation of ₹ 194 Cr as on 15-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Accretion Nutraveda Ltd?
Before investing in Accretion Nutraveda Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.